6nb6
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<SX load='6nb6' size='340' side='right' viewer='molstar' caption='[[6nb6]], [[Resolution|resolution]] 4.20Å' scene=''> | <SX load='6nb6' size='340' side='right' viewer='molstar' caption='[[6nb6]], [[Resolution|resolution]] 4.20Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[6nb6]] is a 7 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[6nb6]] is a 7 chain structure with sequence from [https://en.wikipedia.org/wiki/ ] and [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6NB6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6NB6 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand= | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene></td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6nb3|6nb3]], [[6nb4|6nb4]], [[6nb5|6nb5]], [[6nb7|6nb7]], [[6nb8|6nb8]]</td></tr> | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[6nb3|6nb3]], [[6nb4|6nb4]], [[6nb5|6nb5]], [[6nb7|6nb7]], [[6nb8|6nb8]]</div></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6nb6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6nb6 OCA], [https://pdbe.org/6nb6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6nb6 RCSB], [https://www.ebi.ac.uk/pdbsum/6nb6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6nb6 ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [[ | + | [[https://www.uniprot.org/uniprot/SPIKE_CVHSA SPIKE_CVHSA]] S1 attaches the virion to the cell membrane by interacting with human ACE2 and CLEC4M/DC-SIGNR, initiating the infection. Binding to the receptor and internalization of the virus into the endosomes of the host cell probably induces conformational changes in the S glycoprotein. Proteolysis by cathepsin CTSL may unmask the fusion peptide of S2 and activate membranes fusion within endosomes. S2 is a class I viral fusion protein. Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 21: | Line 21: | ||
==See Also== | ==See Also== | ||
+ | *[[Sandbox 3001|Sandbox 3001]] | ||
*[[Spike protein|Spike protein]] | *[[Spike protein|Spike protein]] | ||
== References == | == References == |
Revision as of 10:34, 18 March 2021
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1)
|
Categories: Human | Large Structures | Cameroni, E | Corti, D | Gopal, R | Lanzavecchia, A | Mian, D | Park, Y J | Quispe, J | Rey, F A | Structural genomic | Snijder, S | Tortorici, M A | Veesler, D | Walls, A C | Xiong, X | Zambon, M | Coronavirus spike glycoprotein | Human neutralizing antibody | Mers-cov | Sars-cov | Ssgcid | Virus